IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (IDXX) Stock Overview

Explore IDEXX Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IDXXNASDAQ
HealthcareMedical - Diagnostics & Research
$577.83
$37.15(6.87%)
U.S. Market is Open · 15:31

IDEXX Laboratories, Inc. (IDXX)

Meyka AI Score

Z

Key Financials

Market Cap43.9B
P/E Ratio41.01
EPS (TTM)$13.58
ROE0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$648.55
3 Months$798.01
1 Year Target$592.82

IDXX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IDEXX Laboratories, Inc. (IDXX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $592.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.01 and a market capitalization of 43.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.02%
5-Day Change
-0.87%
1-Month Change
-2.28%
3-Month Change
-4.09%
6-Month Change
-21.78%
Year-to-Date (YTD) Change
-17.67%
1-Year Change
5.76%
3-Year Change
0.94%
5-Year Change
-15.27%
All-Time (Max) Change
117747.92%

Contact Information

207 556 0300
One IDEXX Drive, Westbrook, ME, 04092

Company Facts

110,000 Employees
IPO DateJun 21, 1991
CountryUS
Actively Trading

Frequently Asked Questions